| 1 |
URL
|
| 2 |
Calabrese F, Pezzuto F, Fortarezza F, et al. Pulmonary pathology and COVID-19: lessons from autopsy. the experience of european pulmonary pathologists[J].
Virchows Arch,
2020,
477(3): 359-372.
|
| 3 |
任成山，林 辉，杨仕明，等. 冠状病毒及新型冠状病毒肺炎防控策略[J/CD].
中华肺部疾病杂志(电子版),
2020,
13(1): 1-5.
|
| 4 |
Duarte-Neto AN, Monteiro RAA, da Silva LFF, et al. Pulmonary and systemic involvement in COVID-19 patients assessed with ultrasound-guided minimally invasive autopsy[J].
Histopathology,
2020,
77(2): 186-197.
|
| 5 |
刘 茜，王荣帅，屈国强，等. 新型冠状病毒肺炎死亡尸体系统解剖大体观察报告[J].
法医学杂志，
2020,
36(1): 21-23.
|
| 6 |
中国疾病预防控制中心新型冠状病毒肺炎应急响应机制流行病学组. 新型冠状病毒肺炎流行病学特征分析[J].
中华流行病学杂志，
2020,
41(2): 145-151.
|
| 7 |
Guan WJ, Ni ZY, Hu Y, et al. Clinical characteristics of coronavirus disease 2019 in China[J].
N Engl J Med,
2020,
382(18): 1708-1720.
|
| 8 |
CDC COVID-19 Response Team. Severe outcomes among patients with coronavirus disease 2019 (COVID-19)-United States, February 12-March 16, 2020[J].
MMWR Morb Mortal Wkly Rep,
2020,
69(12): 343-346.
|
| 9 |
林连君，朱 蕾，时国朝，等. 老年新型冠状病毒肺炎诊治与防控专家共识[J].
中华内科杂志，
2020,
59(8): 588-597.
|
| 10 |
Singh AK, Gupta R, Misra A. Comorbidities in COVID-19: Outcomes in hypertensive cohort and controversies with renin an-giotensin system blockers[J].
Diabetes Metab Syndr,
2020,
14(4): 283-287.
|
| 11 |
Yang J, Zheng Y, Gou X, et al. Prevalence of comorbidities and its effects in patients infected with SARS-CoV-2: a systematic review and meta-analysis[J].
IJID,
2020,
94: 91-95.
|
| 12 |
Nicoli F, Paudel D, Solis-Soto MT. Old and new coronaviruses in the elderly[J].
Aging (Albany NY),
2021,
13(9): 12295-12296.
|
| 13 |
国家卫生健康委员会. 新型冠状病毒肺炎诊疗方案(试行第七版)[BE/OL]. 2020-03-03.)
URL
|
| 14 |
International diabetes federation guideline development group. global guideline for type2 diabetes[J].
Diabetes Res Clin Pract,
2014,
104: 1-52.
|
| 15 |
Ramachandran A, Snehalatha C, Shetty AS, et al. Trends in prevalence of diabetes in Asian countries[J].
World J Diabetes,
2012,
3(6): 110-117.
|
| 16 |
Whiting DR, Guariguata L, Weil C, et al. IDF diabetes atlas: global estimates of the prevalence of diabetes for 2011 and 2030[J].
Diabetes Res Clin Pract,
2011,
94(3): 311-321.
|
| 17 |
中华医学会糖尿病学分会．中国2型糖尿病防治指南(2017年版)[J].
中华糖尿病杂志，
2018,
10(1): 4-67.
|
| 18 |
Yan RH, Zhang YY, Li YN, et al. Structural basis for the recognition of SARS-CoV-2 by full-length human ACE2[J].
Science,
2020,
367(6485): 1444-1448.
|
| 19 |
Beyerstedt S, Casaro EB, Rangel ÉB. COVID-19: angiotensin-converting enzyme 2 (ACE2) expressions and tissue susceptibility to SARS-CoV-2 infection [J].
Eur J Clin Microbiol Infect Dis,
2021,
40(5): 905-919.
|
| 20 |
Bai Y, Yao L, Wei T, et al. Presumed asymptomatic carrier transmission of COVID-19[J].
JAMA,
2020,
323(14): 1406-1407.
|
| 21 |
Chenn S, Zhou M, Dong X, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China：a descriptive study[J].
Lancet,
2020,
395(10223): 507-513.
|
| 22 |
Hu L, Chen S, Fu Y, et al. Risk factors associated with clinical outcomes in 323 coronavirus disease 2019 (COVID-19) hospitalized patients in Wuhan, China[J].
Clin Infect Dis,
2020,
71(16): 2089-2098.
|
| 23 |
Shi H, Han X, Jiang N, et al. Radiological findings from 81 patients with COVID-19 pneumonia in Wuhan, China: a descriptive study[J].
Lancet Infect Dis,
2020,
20(4): 425-434.
|
| 24 |
Wrapp D, Wang N, Corbett KS, et al. Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation[J].
Science,
2020,
367(6483): 1260-1263.
|
| 25 |
Yang JK, Lin SS, Ji XJ, Guo LM. Binding of SARS coronavirus to its receptor damages islets and causes acute diabetes[J].
Acta Diabetol,
2010,
47(3): 193-199.
|
| 26 |
Fu Y, Cheng Y, Wu Y. Understanding SARS-CoV-2-mediated inflammatory responses: From mechanisms to potential therapeutic tools [J].
Virol Sin,
2020,
35(3): 266-271.
|
| 27 |
Chakraborty S, Bhattacharyya R, Banerjee D. Infections: A possible risk factor for type 2 diabetes[J].
Adv Clin Chem,
2017,
80: 227-251.
|
| 28 |
王阳春，仝瑞祥，刘 飞，等. 糖尿病患者易感新型冠状病毒的免疫因素分析[J].
中国糖尿病杂志，
2020,
28(3): 176-179.
|
| 29 |
刘 瑶，申虎威. 从微观到宏观探讨COVID-19与糖尿病的发生发展[J].
世界最新医学信息文摘，
2020,
20(4A): 160-161, 163.
|
| 30 |
中华医学会糖尿病学分会. 中国2型糖尿病防治指南(2020年版)[J].
中华内分泌代谢杂志，
2021,
37(4): 311-398.
|